Literature DB >> 1108778

Treatment of respiratory Klebsiella pneumoniae infection in mice with aerosols of kanamycin.

R F Berendt, G G Long, J S Walker.   

Abstract

Aerosols of kanamycin resulted in greater survival of mice challenged with respiratory Klebsiella pneumoniae than the same dosage given intramuscularly. Determinations of viable bacteria in the blood and lungs revealed that aerosolized kanamycin was most effective when infection was confined to the lungs. After the organisms had spread to other areas, however, aerosol therapy was still more effective than intramuscular therapy, but only one-half the infected mice survived.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1108778      PMCID: PMC429426          DOI: 10.1128/AAC.8.5.585

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  SINGLE-STAGE IMPACTION DEVICE FOR PARTICLE SIZING BIOLOGICAL AEROSOLS.

Authors:  J E MALLIGO; L S IDOINE
Journal:  Appl Microbiol       Date:  1964-01

2.  An apparatus for the study of airborne infection.

Authors:  D W HENDERSON
Journal:  J Hyg (Lond)       Date:  1952-03

3.  Infection and antibiotic usage at Boston City Hospital: changes in prevalence during the decade 1964-1973.

Authors:  J E McGowan; M Finland
Journal:  J Infect Dis       Date:  1974-04       Impact factor: 5.226

4.  Pseudomonas aeruginosa pneumonia in adults.

Authors:  H D Rose; M G Heckman; J D Unger
Journal:  Am Rev Respir Dis       Date:  1973-03

5.  Bacterial colonization and clinical superinfection of the respiratory tract complicating antibiotic treatment of pneumonia.

Authors:  J R Tillotson; M Finland
Journal:  J Infect Dis       Date:  1969-06       Impact factor: 5.226

6.  [Comparative study of the effect of inhalation and subcutaneous methods of administration of kanamycin during treatment and prevention of experimental pneumonia in albino mice].

Authors:  I I Prokhorova
Journal:  Antibiotiki       Date:  1968-06

7.  Studies of absorption of kanamycin by aerosolization.

Authors:  M Bilodeau; J C Roy; M Giroux
Journal:  Ann N Y Acad Sci       Date:  1966-06-14       Impact factor: 5.691

8.  Nosocomial pneumonia. A continuing major problem.

Authors:  J R Graybill; L W Marshall; P Charache; C K Wallace; V B Melvin
Journal:  Am Rev Respir Dis       Date:  1973-11

Review 9.  Aerosol therapy in acute and chronic respiratory disease.

Authors:  W F Miller
Journal:  Arch Intern Med       Date:  1973-01

10.  Pulmonary absorption and retention of kanamycin after repeated inhalation administration of kanamycin aerosol.

Authors:  R H Teske; S B Miller
Journal:  Appl Microbiol       Date:  1970-04
  10 in total
  11 in total

1.  Relationship of method of administration to respiratory virulence of Klebsiella pneumoniae for mice and squirrel monkeys.

Authors:  R F Berendt
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

2.  Continuous aerosol therapy system using a modified Collison nebulizer.

Authors:  H W Young; J W Dominik; J S Walker; E W Larson
Journal:  J Clin Microbiol       Date:  1977-02       Impact factor: 5.948

3.  Experimental respiratory tract infection with Klebsiella pneumoniae DT-S in mice: chemotherapy with kanamycin.

Authors:  T Nishi; K Tsuchiya
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

4.  Nonhuman primate model for the study of respiratory Klebsiella pneumoniae infection.

Authors:  R F Berendt; G L Knutsen; M C Powanda
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

5.  Changes in whole blood and serum components of grivet monkeys with experimental respiratory Francisella tularensis infection.

Authors:  P Hambleton; A Baskerville; P W Harris-Smith; N E Bailey
Journal:  Br J Exp Pathol       Date:  1978-12

6.  Therapeutic effect of cefozopran (SCE-2787), a new parenteral cephalosporin, against experimental infections in mice.

Authors:  Y Iizawa; K Okonogi; R Hayashi; T Iwahi; T Yamazaki; A Imada
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

7.  Antibacterial effect of scandium and indium complexes of enterochelin on Klebsiella pneumoniae.

Authors:  H J Rogers; C Synge; V E Woods
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

8.  Pentamidine aerosol in prophylaxis and treatment of murine Pneumocystis carinii pneumonia.

Authors:  P M Girard; M Brun-Pascaud; R Farinotti; L Tamisier; S Kernbaum
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

9.  In vitro and in vivo morphological response of Klebsiella pneumoniae to cefotiam and cefazolin.

Authors:  M Nakao; T Nishi; K Tsuchiya
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

10.  Pathogenesis of respiratory Klebsiella pneumoniae infection in rats: bacteriological and histological findings and metabolic alterations.

Authors:  R F Berendt; G G Long; F B Abeles; P G Canonico; M R Elwell; M C Powanda
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.